The next board meeting for Adaptimmune Therapeutics PLC (ADR) is on 14 Apr 2026 for the purpose of Adaptimmune Therapeutics PLC Annual Report for 2025See details
Adaptimmune Therapeutics PLC (ADR) has a share price target of US$ 1, revenue growth forecast of -77.3%, and profit growth estimate of -31.3% for FY25, based on top 3 analyst calls.